SCHEMBL29280989

SCHEMBL29280989

Cc1ccc(Br)c(C(C)CO)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.38
CHRM1 P11229 2/20 0.38
ADRA1A P35348 2/20 0.38
TRPA1 O75762 2/20 0.38
SLC6A2 P23975 1/20 0.38
HTR2B P41595 1/20 0.38
SRC P12931 1/20 0.35
ACE2 Q9BYF1 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
MAPT P10636 2/20 0.32
ESR1 P03372 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32
KCNE1 P15382 1/20 0.32
CHRM3 P20309 1/20 0.32
PTGS1 P23219 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31383860 0.85 LMNA (0.42) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL16951448 0.79 LMNA (0.33) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL2477156 0.78 LMNA (0.42) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL135819 0.78 LMNA (0.42) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL5525837 0.77 LMNA (0.50) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL20738544 0.77 LMNA (0.38) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL20738712 0.76 TRPA1 (0.45) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL27777980 0.75 LMNA (0.39) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL26261042 0.74 LMNA (0.64) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL12180459 0.74 ACHE (0.48) LMNACHRM1ADRA1ATRPA1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117836294-A Biological antagonist containing aromatic ring, preparation method and application thereof 上海翰森生物医药科技有限公司 2024-04-05 CN disclosed